Literature DB >> 14978144

Neurological syndromes and the traveller: an approach to differential diagnosis.

J N Day1, D G Lalloo.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 14978144      PMCID: PMC1765648          DOI: 10.1136/jnnp.2003.034330

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study.

Authors:  J Crawley; C Waruiru; S Mithwani; I Mwangi; W Watkins; D Ouma; P Winstanley; T Peto; K Marsh
Journal:  Lancet       Date:  2000-02-26       Impact factor: 79.321

Review 2.  Recent advances in Japanese encephalitis.

Authors:  Tom Solomon
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

Review 3.  Viral encephalitis: familiar infections and emerging pathogens.

Authors:  Richard J Whitley; John W Gnann
Journal:  Lancet       Date:  2002-02-09       Impact factor: 79.321

Review 4.  Treatment of human African trypanosomiasis--present situation and needs for research and development.

Authors:  Dominique Legros; Gaëlle Ollivier; Marc Gastellu-Etchegorry; Christophe Paquet; Christian Burri; Jean Jannin; Philippe Büscher
Journal:  Lancet Infect Dis       Date:  2002-07       Impact factor: 25.071

5.  Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria.

Authors:  Paul N Newton; Brian J Angus; Wirongrong Chierakul; Arjen Dondorp; Ronatrai Ruangveerayuth; Kamolrat Silamut; Pramote Teerapong; Yupin Suputtamongkol; Sornchai Looareesuwan; Nicholas J White
Journal:  Clin Infect Dis       Date:  2003-06-23       Impact factor: 9.079

  5 in total
  1 in total

Review 1.  Infectious encephalitis: Management without etiological diagnosis 48hours after onset.

Authors:  P Fillatre; Y Crabol; P Morand; L Piroth; J Honnorat; J P Stahl; M Lecuit
Journal:  Med Mal Infect       Date:  2017-03-15       Impact factor: 2.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.